MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in ...
A new liquid-based pap test for cervical cancer screening has been made available to women at the King Edward VII Memorial Hospital. The ThinPrep pap test is more effective at finding early ...
Women in the Greater Auckland area will be able to get a ThinPrep cervical smear test from their doctor at no extra charge from today. Previously, there was an additional charge from the doctor for ...
Hologic, Inc. HOLX recently announced the receipt of FDA premarket approval (PMA) of ThinPrep Genesis processor for cytology processing and specimen transfer for downstream applications. Notably, the ...
Women have been going to their gynecologists for Pap tests for more than 50 years. And their vigilance has paid off: Mortality rates from cervical cancer have dropped 70%, according to the American ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe. The system features increased ...
New instrument offers workflow, automation, chain of custody and ergonomic benefits to clinical labs Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep Genesis processor for cytology slide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results